Tamas Beothe

发表

P53 mutation and LOH at chromosome 9 in urothelial carcinoma.

Tamas Beothe, A. Nagy, L. Farkas, 2012, Anticancer research.

How useful is α‐methylacyl‐CoA racemase (AMACR) immunohistochemistry in the differential diagnosis of kidney cancers?

Tamas Beothe, G. Kovacs, A. Szponar, 2010, Histopathology.

Homozygous losses detected by array comparative genomic hybridization in multiplex urothelial carcinomas of the bladder.

Tamas Beothe, G. Kovacs, D. Zubakov, 2015, Cancer Genetics.

FAPα and αSMA mark different subsets of fibroblasts in normal kidney and conventional renal cell carcinoma

Tamas Beothe, G. Kovacs, M. Yusenko, 2022, Neoplasia.

Sciellin is a marker for papillary renal cell tumours

Tamas Beothe, A. Nagy, G. Kovacs, 2015, Virchows Archiv.

Lack of TMEM27 expression is associated with postoperative progression of clinically localized conventional renal cell carcinoma

Tamas Beothe, G. Kovacs, N. Farkas, 2016, Journal of Cancer Research and Clinical Oncology.

Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma.

Tamas Beothe, G. Kovacs, N. Kuroda, 2003, Cancer research.

Deletion of Chromosome 3 p 14 . 2p 25 Involving the VHL and FHIT Genes in Conventional Renal Cell Carcinoma 1

Tamas Beothe, G. Kovacs, N. Kuroda, 2003 .

Lack of VEGFA/KDR Signaling in Conventional Renal Cell Carcinoma Explains the Low Efficacy of Target Therapy and Frequent Adverse Events

Tamas Beothe, G. Kovacs, M. Yusenko, 2024, International journal of molecular sciences.